LGALS3 and heart failure: Gal3 is a glycoprotein-binding protein that is secreted by activated cardiac macrophages [10]. In 2010, the Food and Drug Administration (FDA) sanctioned Gal-3 as a novel biomarker for stratifying the risk of heart failure (HF) [10].